R. Kahraman Et Al. , "Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?," THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, pp.1295-1301, 2017
Kahraman, R. Et Al. 2017. Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?. THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13 , 1295-1301.
Kahraman, R., Calhan, T., Sahin, A., Ozdil, K., Caliskan, Z., Bireller, E. S., ... ÇAKMAKOĞLU, B.(2017). Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?. THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, 1295-1301.
Kahraman, Resul Et Al. "Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?," THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, 1295-1301, 2017
Kahraman, Resul Et Al. "Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?." THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, pp.1295-1301, 2017
Kahraman, R. Et Al. (2017) . "Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?." THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, pp.1295-1301.
@article{article, author={Resul Kahraman Et Al. }, title={Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?}, journal={THERAPEUTICS AND CLINICAL RISK MANAGEMENT}, year=2017, pages={1295-1301} }